Japan Insulin Infusion Pump Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 55.96 Million |
| Market Size (2029) | USD 68.41 Million |
| CAGR (2024 - 2029) | > 4.10 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Japan Insulin Infusion Pump Market Analysis
The Japan Insulin Infusion Pump Market size is estimated at USD 53.76 million in 2023, and is expected to reach USD 65.72 million by 2028, growing at a CAGR of greater than 4.10% during the forecast period (2023-2028).
The Japanese market for diabetes insulin infusion pumps is witnessing a robust growth trajectory, fueled by the increase in diabetes cases and proactive industry initiatives, including expanding product portfolios and the increasing prevalence of diabetes.
With Japan's diabetic population on the rise, the demand for insulin infusion pumps that are crucial for managing blood glucose levels is poised for a significant uptick. Data from the IDF Diabetes Atlas highlighted the widespread prevalence of diabetes across various age brackets, with a pronounced concentration among the working-age segment. In 2022, Japan reported 5.5 thousand diabetics under 20, 43.3 thousand aged 20-59, and 30.5 thousand above 60. Such a high concentration of diabetic people in the working-age group affects the nation's healthcare expenditure. According to IDF Diabetes Atlas, Japan's diabetes cases are expected to rise further.
As the diabetic populace expands, Japan is experiencing a surge in new product introductions and guideline updates. For instance, in February 2023, Medtronic Japan Co. Ltd secured manufacturing and sales approval for the MiniMed 780G System. This marked a milestone as Japan's first insulin pump featuring the Advanced Hybrid Closed Loop technology with automatic insulin injection for basal and correction insulin.
The growing prevalence of diabetes in Japan is driving significant market growth. Market players are responding with innovative products and expanded capacities, positioning the market for continued expansion.
Japan Insulin Infusion Pump Market Trends
The Insulin Pump Segment is Expected to Witness Growth Over the Forecast Period
The insulin pump mirrors the human pancreas; it administers insulin continuously or as needed, replacing traditional daily injections or insulin pens. Widely adopted by individuals with type 1 diabetes (T1DM), these pumps offer a time-tested alternative, ensuring near-physiological insulin delivery when the pancreas falters. Notably, pumps equipped with remote controls empower parents to manage insulin dosages from a distance, even as their child plays or eats.
Compared to injections, insulin pumps offer more precise dosing, minimize blood glucose fluctuations, and are less discomforting. These advantages are propelling the market's growth trajectory.
Continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring systems (CGMs) have revolutionized patient care, especially in ambulatory settings. Market players are intensifying collaborations and product developments to bolster their market foothold. For instance, in March 2023, BlueStar, a joint venture between Astellas Pharma and Welldoc, partnered with Roche DC Japan to integrate its blood glucose self-monitoring device, Accu-Check Guide Me, with BlueStar technology, which was slated for clinical trials in Japan in fiscal year 2023. With obesity rates on the rise, a surge in hereditary risks for type 2 diabetes, and a growing number of type 1 diabetes cases, the insulin pump segment is poised for further expansion.
The Prevalence of Diabetes is Rising
Diabetes poses a significant health challenge in Japan. The country's surging diabetes rates have set off alarm bells, prompting urgent responses from healthcare authorities and stakeholders.
Japan's Ministry of Health, Labor, and Welfare has highlighted diabetes as a top health priority. Of particular concern is the economic strain, especially for type 2 diabetes patients with additional conditions like hypertension, hyperlipidemia, or those facing complications.
Diabetes is on the rise across all age brackets in Japan, a surge attributed to a combination of factors: a burgeoning obese population, unhealthy dietary habits, and sedentary lifestyles. According to the International Diabetes Federation (IDF), Japan's diabetic populace is set to hit 10,542.7 thousand by 2030 and 10,117.9 thousand by 2045.
Japan's aging population, especially susceptible to diseases, combined with increasing obesity due to sedentary lifestyles and erratic eating patterns, are primary drivers behind the nation's climbing diabetes rates. As of December 2023, data from the Ministry of Internal Affairs and Communications (May 2024) revealed that nearly 30% of Japan's populace was aged 65 or older. With this aging demographic, Japan anticipates a further surge in diabetes cases, leading to increased demand for oral anti-diabetic medications.
Given the mounting prevalence of diabetes and Japan's proactive approach, the insulin infusion pump market is primed for substantial growth during the forecast period.
Japan's struggle with diabetes presents a dual narrative of challenges and opportunities. The nation's dedication to combatting this health crisis through innovative solutions and updated protocols will play a pivotal role in curbing the future health and economic ramifications of diabetes.
Japan Insulin Infusion Pump Industry Overview
Due to the existence of only a few big businesses operating internationally and locally, the insulin infusion pump market is concentrated. The competitive landscape includes an examination of a few well-known worldwide and local organizations, such as Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care.
Japan Insulin Infusion Pump Market Leaders
-
Medtronics
-
Ascensia Diabetes Care
-
Insulet Corporation
-
Tandem Diabetes Care
-
Ypsomped
*Disclaimer: Major Players sorted in no particular order
Japan Insulin Infusion Pump Market News
- May 2024: Dexcom Japan LLC unveiled its latest offering, the real-time CGM Dexcom G7 CGM System in Japan. This system is available to all diabetes patients aged 2 years and above who self-administer insulin at least once daily and are covered under insurance medical care. This system is a complementary support for insulin pumps in the country,
- September 2023: Kobe University's findings highlighted the benefits of SAP therapy (insulin pump therapy with CGM function) for pregnant women with type 1 diabetes. The therapy was shown to mitigate the risk of fetal overgrowth.
Japan Insulin Infusion Pump Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Diabetes Prevalence in Japan
4.2.2 Government Support Initiatives to Construct the Spread of Diabetes
4.3 Market Restraints
4.3.1 Limited Awareness About the Pump and Related-Technology
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size - Value USD)
5.1 By Product Type
5.1.1 Insulin Pump Device
5.1.2 Infusion Set
5.1.3 Reservoir
5.2 By End User
5.2.1 Hospitals/Clinics
5.2.2 Home Care
5.2.3 Others
6. MARKET INDICATORS
6.1 Type-1 Diabetic Population (2021-2029)
6.2 Type-2 Diabetic Population (2021-2029)
7. COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Medtronic
7.1.2 Insulet corporation
7.1.3 Ypsomed
7.1.4 Tandem Diabetes Care
7.1.5 Ascensia Diabetes Care
- *List Not Exhaustive
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
Japan Insulin Infusion Pump Industry Segmentation
An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump comprises a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes.
Japan’s insulin infusion pump market is segmented by component and end user. By component, the market is segmented into pump device, infusion set, and reservoir. By end user, the market is segmented into hospitals/clinics, home care settings, and others. The report offers the value (USD) for all the above segments.
| By Product Type | |
| Insulin Pump Device | |
| Infusion Set | |
| Reservoir |
| By End User | |
| Hospitals/Clinics | |
| Home Care | |
| Others |
Japan Insulin Infusion Pump Market Research FAQs
How big is the Japan Insulin Infusion Pump Market?
The Japan Insulin Infusion Pump Market size is expected to reach USD 55.96 million in 2024 and grow at a CAGR of greater than 4.10% to reach USD 68.41 million by 2029.
What is the current Japan Insulin Infusion Pump Market size?
In 2024, the Japan Insulin Infusion Pump Market size is expected to reach USD 55.96 million.
Who are the key players in Japan Insulin Infusion Pump Market?
Medtronics, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care and Ypsomped are the major companies operating in the Japan Insulin Infusion Pump Market.
What years does this Japan Insulin Infusion Pump Market cover, and what was the market size in 2023?
In 2023, the Japan Insulin Infusion Pump Market size was estimated at USD 53.67 million. The report covers the Japan Insulin Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Insulin Infusion Pump Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Japan Insulin Infusion Pump Industry Report
Statistics for the 2024 Japan Insulin Infusion Pump market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Japan Insulin Infusion Pump analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
